| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/2002 | WO2002026741A1 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN |
| 04/04/2002 | WO2002026740A1 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain |
| 04/04/2002 | WO2002026739A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 04/04/2002 | WO2002026738A1 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN |
| 04/04/2002 | WO2002026737A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| 04/04/2002 | WO2002026736A1 A thiazolidinedione derivative and its use as antidiabetic |
| 04/04/2002 | WO2002026735A1 Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 04/04/2002 | WO2002026734A1 PIPERAZIN-2-ONE AMIDES AS INHIBITORS OF FACTOR Xa |
| 04/04/2002 | WO2002026733A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 04/04/2002 | WO2002026730A2 Fluorinated quinolones as antimitotic and antitumor agents |
| 04/04/2002 | WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026724A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026722A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026717A2 Hydroxy acid integrin antagonists |
| 04/04/2002 | WO2002026716A2 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
| 04/04/2002 | WO2002026713A1 Antiparasitic compounds |
| 04/04/2002 | WO2002026711A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 04/04/2002 | WO2002026708A1 Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient |
| 04/04/2002 | WO2002026704A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
| 04/04/2002 | WO2002026696A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 04/04/2002 | WO2002026694A1 O-substituted 6-methyl-tramadol derivatives |
| 04/04/2002 | WO2002026325A2 Restoration of perturbed barrier function by application of antiandrogens |
| 04/04/2002 | WO2002026324A2 Tocol-based compositions containing amiodarone |
| 04/04/2002 | WO2002026281A1 Coated medical devices |
| 04/04/2002 | WO2002026279A1 E-ptfe foil impregnated with an encapsulated bioactive substance |
| 04/04/2002 | WO2002026277A2 Stabilized hydrogen peroxide solutions |
| 04/04/2002 | WO2002026249A2 Methods for inhibition of viral infection |
| 04/04/2002 | WO2002026245A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions |
| 04/04/2002 | WO2002026242A2 Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| 04/04/2002 | WO2002026240A2 Inhibition of antigen presentation with poorly catabolized polymers |
| 04/04/2002 | WO2002026239A1 Analgesic and glucosamine compositions |
| 04/04/2002 | WO2002026238A1 Phosphate derivative supplements |
| 04/04/2002 | WO2002026236A1 Tumor cell killing by cell cycle checkpoint abrogation combined with inhibition of the 'classical' mitogen activated protein (map) kinase pathway |
| 04/04/2002 | WO2002026235A1 Dispersible pharmaceutical cephalosporin compositions, preparation and use thereof |
| 04/04/2002 | WO2002026234A1 Eye drops comprising acyclovir suspension |
| 04/04/2002 | WO2002026232A1 Pharmaceutical composition for transmucosal delivery of a dihydroergotamine/metoclopramide combination |
| 04/04/2002 | WO2002026231A1 Use of nitroxides for the treatment of vascular disorders in a diabetic mammal |
| 04/04/2002 | WO2002026227A1 Lactone integrin antagonists |
| 04/04/2002 | WO2002026226A1 Pharmaceutical composition of dihydroartemisinin for treating malaria |
| 04/04/2002 | WO2002026225A1 Methods for in vivo reduction of free radical levels and compositions useful therefor |
| 04/04/2002 | WO2002026224A2 Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| 04/04/2002 | WO2002026223A2 Catecholamine pharmaceutical compositions and methods |
| 04/04/2002 | WO2002026222A2 Method of achieving overnight laxation and control of bowel function |
| 04/04/2002 | WO2002026219A2 Otic microbial combinations for treatment of animals with ruptured tympanic membrane |
| 04/04/2002 | WO2002026218A2 Fatty acid analogues for the treatment of proliferative skin disorders |
| 04/04/2002 | WO2002026217A2 Composition for the transdermal delivery of fentanyl |
| 04/04/2002 | WO2002026216A1 Pharmaceutical oxan preparation |
| 04/04/2002 | WO2002026215A2 Thermogelling biodegradable aqueous polymer solution |
| 04/04/2002 | WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | WO2002026211A1 Topical polymeric antimicrobial emulsion |
| 04/04/2002 | WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | WO2002026104A2 A combination of appetite controlling agents which create a synergy and produce a satiating result |
| 04/04/2002 | WO2002026020A2 Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics |
| 04/04/2002 | WO2002014281A8 Pyridine derivatives as inhibitors of p38 |
| 04/04/2002 | WO2002010339A3 Gene expression profile for kshv infection and methods for treating same |
| 04/04/2002 | WO2002008195A8 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms |
| 04/04/2002 | WO2002006248A3 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 04/04/2002 | WO2002004421A3 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics |
| 04/04/2002 | WO2002004407A3 7-substituted tetracycline compounds |
| 04/04/2002 | WO2002002084A8 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 04/04/2002 | WO2002000662B1 Improvements in and relating to chromophores |
| 04/04/2002 | WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor |
| 04/04/2002 | WO2002000042A3 Compositions and methods for body weight management |
| 04/04/2002 | WO2001097815A3 Use of glucocorticosteroids for producing a medicament to treat oligotrichia |
| 04/04/2002 | WO2001097795A3 Systems and methods for treating a mucosal surface |
| 04/04/2002 | WO2001097771A3 Preparations that contain an extract of the plant pistia stratiotes |
| 04/04/2002 | WO2001094347A8 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 04/04/2002 | WO2001094301A3 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 04/04/2002 | WO2001093844A3 Compositions comprising a serotonin transporter inhibitor and a 5-ht1d antagonist |
| 04/04/2002 | WO2001091735A3 Use of aloe-emodin in the treatment of neuroectodermal tumors |
| 04/04/2002 | WO2001091733A3 Combination of active substances containing montirelin and a compound having an opioid effect |
| 04/04/2002 | WO2001090306A3 Compositions and methods for modulating tumor specific expression |
| 04/04/2002 | WO2001090137A3 NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11β-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17β-METHOXY-ESTRA-4,9-DIEN-3-ONE |
| 04/04/2002 | WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists |
| 04/04/2002 | WO2001089577A3 Conjugates of aminodrugs comprising an oxime bond |
| 04/04/2002 | WO2001089451A3 Protease inhibitors |
| 04/04/2002 | WO2001089449A3 Phospholipase d effectors for therapy and screening |
| 04/04/2002 | WO2001087376A8 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 04/04/2002 | WO2001087263A3 Delivery systems for treatment of vascular disease |
| 04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
| 04/04/2002 | WO2001085910A3 Agents that modulate dna-pk activity and methods of use thereof |
| 04/04/2002 | WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists |
| 04/04/2002 | WO2001085142A8 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 04/04/2002 | WO2001083714A3 Composition and methods for treating photoreceptor degeneration |
| 04/04/2002 | WO2001081332A3 2-fluorobenzenesulfonyl compounds for the treatment of inflammation |
| 04/04/2002 | WO2001081308A3 Aminopiperidines for use as glyt-1 inhibitors |
| 04/04/2002 | WO2001080841A3 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
| 04/04/2002 | WO2001080830A3 Pharmacotherapeutic process and composition for central nervous system disorders |
| 04/04/2002 | WO2001077294A3 Hpv-specific short-mers |
| 04/04/2002 | WO2001074815A3 Phenyl-substituted imidazopyridines |
| 04/04/2002 | WO2001074810A3 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists |
| 04/04/2002 | WO2001074773A3 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 04/04/2002 | WO2001072846A3 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 04/04/2002 | WO2001071022A3 Lpa receptor agonists and antagonists and methods of use |
| 04/04/2002 | WO2001071017A3 Modified nodavirus rna for gene delivery |
| 04/04/2002 | WO2001070678A3 Substituted biphenyl derivatives |